David Kendall named Zealand Pharma CMO
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Subscribe To Our Newsletter & Stay Updated